{"nct_id":"NCT00719264","title":"Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer","status":"COMPLETED","status_verified_date":"2017-02","start_date":"2008-11-12","start_date_type":"ACTUAL","primary_completion_date":"2011-12-31","primary_completion_date_type":"ACTUAL","completion_date":"2013-04-15","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}